Ignite Creation Date:
2025-12-24 @ 10:57 PM
Ignite Modification Date:
2025-12-31 @ 3:02 PM
Study NCT ID:
NCT00735969
Status:
COMPLETED
Last Update Posted:
2014-10-20
First Post:
2008-08-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
High-Dose Ribavirin and Peginterferon to Treat Chronic Hepatitis C Genotype 1
Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
080149
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None